Fig. 1From: Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccineLocal reactions and systemic events in patients with RMD and healthy controls after the first and second dose of vaccine. Other adverse events included headache, nausea, diarrhea, hypertension, and lymphadenopathy. Frequency of different adverse events after first (A) and second (B) dose of vaccine. AE, adverse events; HC, healthy controls; RMD, rheumatic musculoskeletal diseaseBack to article page